Liu, C., Zhou, C., Xia, W., Zhou, Y., Qiu, Y., Weng, J., . . . Hung, M. (2024). Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications, 15(1), 1009-18. https://doi.org/10.1038/s41467-024-45215-0
Chicago Style (17th ed.) CitationLiu, Chunxiao, et al. "Targeting ALK Averts Ribonuclease 1-induced Immunosuppression and Enhances Antitumor Immunity in Hepatocellular Carcinoma." Nature Communications 15, no. 1 (2024): 1009-18. https://doi.org/10.1038/s41467-024-45215-0.
MLA (9th ed.) CitationLiu, Chunxiao, et al. "Targeting ALK Averts Ribonuclease 1-induced Immunosuppression and Enhances Antitumor Immunity in Hepatocellular Carcinoma." Nature Communications, vol. 15, no. 1, 2024, pp. 1009-18, https://doi.org/10.1038/s41467-024-45215-0.